Document is current
Any future updates will be listed below
-
Authors
Yoshida, Tsuneyasu
Murotani, Yoshiki
Murata, Koichi
Imai, Hirohiko
Iwasaki, Takeshi
Nakayama, Yoichi
Katsushima, Masao
Shirakashi, Mirei
Nakashima, Ran
Watanabe, Ryu
Murakami, Kosaku
Yoshifuji, Hajime
Morinobu, Akio
Hashimoto, Motomu
-
Funding
Funding for this research was provided by:
Eli Lilly Japan K.K (Not applicable)
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 20 June 2025
First Online: 10 July 2025
Declarations
:
: All animal experiments were approved by the Kyoto University Animal Ethics Committee (approval number Medkyo 16106–23104). All experiments using human samples were approved by the ethics committee of Kyoto University Graduate School and Faculty of Medicine (approval number R1166-3).
: Not applicable.
: TY has received speaker fees from AbbVie GK, Asahi Kasei Pharma Corp., and Eli Lilly Japan K.K. MH has received research grants from AbbVie GK, Asahi Kasei Pharma Corp., Astellas Pharma Inc., Bristol-Myers Squibb., Eisai Co. Ltd., Daiichi Sankyo Co. Ltd., Eli Lilly Japan K.K., Novartis Pharma Co. Ltd., Taisho Toyama Co. Ltd., and Towa Pharma Co. Ltd., and speaker fees from Bristol-Myers Squibb., Chugai Pharmaceutical Co. Ltd., Eisai Co. Ltd., Eli Lilly Japan K.K., and Mitsubishi Tanabe Pharma Corp. Ltd. YM has received honoraria from Asahi Kasei Pharma Corp. RW has received a grant from AbbVie GK, and has received honoraria from AbbVie GK, Chugai Pharmaceutical Co. Ltd., Asahi Kasei Pharma Corp., GlaxoSmithKline, Eli Lilly Japan K.K., and UCB Japan. KM has received honoraria from Chugai Pharmaceutical Co., Ltd., and Asahi Kasei Pharma Corp. AM has received research grants from AbbVie GK, Asahi Kasei Pharma Corp., Chugai Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corp. Ltd., and Eisai Co. Ltd., and has received honoraria from AbbVie GK, Chugai Pharmaceutical Co. Ltd., Eli Lilly Japan K.K., Eisai Co. Ltd., Pfizer Inc., Bristol-Myers Squibb., Mitsubishi Tanabe Pharma Corp., Astellas Pharma Inc., and Gilead Sciences Japan.
